The Marcus Corporation operates as a Milwaukee-based entertainment and hospitality firm with two main segments. Marcus Theatres ranks as the fourth-largest movie theatre circuit in the United States, running roughly 975 screens at 77 locations across 17 states through the Marcus Theatres, Movie Tavern by Marcus, and BistroPlex brands. Marcus Hotels & Resorts owns and manages about 18 hotels, resorts, and related properties in eight states, featuring notable upper-upscale assets such as The Pfister Hotel, Grand Geneva Resort & Spa, and the Hilton Milwaukee.
Investors track MCS for its exposure to two consumer cycles: theatrical exhibition tied to film slates and attendance, plus lodging that follows leisure, group, and business travel trends. The company also maintains significant owned real estate, which supports its balance sheet and long-term value. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Over the last 30 days, MCS fell from a closing price of $28.83 to $25.67, a decline of roughly 11%. The drop occurred gradually rather than in one session, with a sharper pullback in late October right after earnings, followed by a steadier drift lower into November.
This 30-day action fits into a broader corrective phase. Over the last quarter, the stock has declined about 13%, moving from roughly $29.57 to $25.67. Shares had reached a peak near $31 in early August 2026 after a strong advance, and the recent quarter has featured consolidation and profit-taking rather than any fundamental breakdown.
The standout event in the 30-day window was the late-October release of third-quarter 2026 results. Marcus posted record quarterly revenue of $237.8 million, up 13.1% year over year, with operating income rising 33.2% to $30.3 million and diluted EPS increasing 15.4% to $0.60. The theatre division drove much of the growth, with revenue up 20.9% and comparable attendance up 16.8%, helped by releases such as Spider-Man: Brand New Day and The Odyssey.
Even with these strong numbers, the stock sold off afterward in a classic sell-the-news reaction after the prior run higher. Profit-taking weighed on shares despite healthy results. Analyst notes were mixed around the same time, with some firms lifting price targets while B. Riley moved to Neutral. Limited fresh catalysts after earnings and a softer hotel outlook added to the gradual decline through November. From what I see, this pattern often follows extended rallies even when operations remain solid.
The roughly 13% drop over the quarter largely reflects normalization after a lengthy advance rather than any weakening in the core business. After peaking near $31 in early August 2026, shares consolidated as investors balanced valuation against still-positive operating trends.
Key influences included record third-quarter revenue in hotels but softer group demand, especially in Milwaukee due to a lighter event calendar, plus storm-related repair costs at Grand Geneva. Management highlighted ongoing travel-cost volatility such as higher gas prices and airfares as potential headwinds. On the positive side, group room booking pace stayed ahead of prior-year levels, and the company reaffirmed lower capital expenditures, which aids free cash flow. These elements created a choppy downward trend over the quarter even as revenue grew in both segments.
Looking ahead, the main variables for MCS include the holiday film lineup and hotel demand trends. Management has highlighted a busy fourth-quarter slate with titles such as The Hunger Games: Sunrise on the Reaping, Dune: Part Three, and Avengers: Doomsday, which could support theatre attendance. On the lodging side, 2027 group room bookings are running ahead of last year, though near-term business travel remains worth monitoring.
Investors should also follow consumer discretionary trends, travel-cost inflation, any shifts in film schedules, and the pace of capital spending as the company reduces outlays after its renovation cycle. Analyst views stay generally positive, but any slowdown in box office or hotel occupancy would represent a notable risk.
When analyzing stocks like MCS, I often review Tickeron’s Trending AI Robots to see how automated strategies are positioned across similar names. This helps surface systematic approaches that complement traditional fundamental work without replacing it.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where MCS declined for three days, in 195 of 303 cases, the price declined further within the following month. The odds of a continued downward trend are 64%.
The Momentum Indicator moved below the 0 level on November 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MCS as a result. In 46 of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 60%.
The Moving Average Convergence Divergence Histogram (MACD) for MCS turned negative on October 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 36 similar instances when the indicator turned negative. In 20 of the 36 cases the stock turned lower in the days that followed. This puts the odds of success at 56%.
MCS moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for MCS crossed bearishly below the 50-day moving average on November 03, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 45%.
The RSI Indicator entered the oversold zone -- be on the watch for MCS's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +1.52% 3-day Advance, the price is estimated to grow further. Considering data from situations where MCS advanced for three days, in 195 of 287 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
MCS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. MCS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 49 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock slightly better than average.
The Tickeron Valuation Rating of 59 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.806) is normal, around the industry mean (12.927). P/E Ratio (35.680) is within average values for comparable stocks, (38.855). Projected Growth (PEG Ratio) (2.499) is also within normal values, averaging (2.430). Dividend Yield (0.013) settles around the average of (0.048) among similar stocks. P/S Ratio (1.082) is also within normal values, averaging (2.898).
The Tickeron SMR rating for this company is 83 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 88 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
an operator of hotels, resorts and movie theaters
Industry MoviesEntertainment